REGENERON PHARMACEUTICALS, INC. Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 343.02 | 214 | 73,406 | 49,951 | 50.2 K to 50 K (-0.43 %) |
| Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 342.44 | 1,399 | 479,074 | 50,165 | 51.6 K to 50.2 K (-2.71 %) |
| Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 341.58 | 3,283 | 1,121,407 | 51,564 | 54.8 K to 51.6 K (-5.99 %) |
| Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 340.56 | 1,355 | 461,459 | 54,847 | 56.2 K to 54.8 K (-2.41 %) |
| Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 339.37 | 567 | 192,423 | 56,202 | 56.8 K to 56.2 K (-1.00 %) |
| Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 338.54 | 712 | 241,040 | 56,769 | 57.5 K to 56.8 K (-1.24 %) |
| Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 337.46 | 270 | 91,114 | 57,481 | 57.8 K to 57.5 K (-0.47 %) |
| Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 336.78 | 200 | 67,356 | 57,751 | 58 K to 57.8 K (-0.35 %) |
| Jan 27 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 30.63 | 500 | 15,315 | 3,380 | |
| Jan 27 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 30.63 | 500 | 15,315 | 13,097 | 12.6 K to 13.1 K (+3.97 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Grant | A | 0.00 | 320 | 0 | 1,830 | 1.5 K to 1.8 K (+21.19 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Grant | A | 0.00 | 320 | 0 | 643 | 323 to 643 (+99.07 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Grant | A | 0.00 | 320 | 0 | 643 | 323 to 643 (+99.07 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Grant | A | 0.00 | 320 | 0 | 10,643 | 10.3 K to 10.6 K (+3.10 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Grant | A | 0.00 | 320 | 0 | 29,143 | 28.8 K to 29.1 K (+1.11 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | Bassler Bonnie L | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | Bassler Bonnie L | Director | Grant | A | 0.00 | 320 | 0 | 643 | 323 to 643 (+99.07 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 24.41 | 15,000 | 366,150 | 0 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Grant | A | 0.00 | 320 | 0 | 115,415 | 115.1 K to 115.4 K (+0.28 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 371.98 | 15,000 | 5,579,700 | 115,095 | 130.1 K to 115.1 K (-11.53 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 24.41 | 15,000 | 366,150 | 130,095 | 115.1 K to 130.1 K (+13.03 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | COLES N ANTHONY | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | COLES N ANTHONY | Director | Grant | A | 0.00 | 320 | 0 | 643 | 323 to 643 (+99.07 %) |